YABAO PHARM.CORP
6003516.470.94% ( +0.06 )
YABAO PHARM.CORP (600351)
Yabao Pharmaceutical Group Co., Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It pr...
- Open
- 6.40
- High
- 6.47
- Low
- 6.33
- Prev. Close
- 6.41
- Volume
- 167.72K
- Turnover
- 107.45M
- Avg Price
- 6.41
- Bid/Ask Ratio
- --
- Amplitude
- 2.18%
- 52wk High
- 8.33
- Volume Ratio
- 0.63
- Turnover Ratio
- 2.42%
YABAO PHARM.CORP Analyst Rating
View MoreForecast & Rating
May 27, 2019Price forecast
¥9.7250.23%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- PR Newswire · May 22 at 06:06 AM
Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
- Zhitong · Nov 3, 2025 at 01:45 AM
YABAO PHARM.CORP: Cumulatively spent 52.1519 million yuan to repurchase 1.14% of shares
- Zhitong · Oct 24, 2025 at 03:10 AM
YABAO PHARM.CORP released its performance for the first three quarters, with a net profit attributable to the parent company of 215 million yuan, a year-on-year decrease of 8.44%
- Zhitong · Oct 13, 2025 at 03:54 AM
YABAO PHARM.CORP: Sitagliptin Metformin Extended-Release Tablets have obtained the drug registration certificate
- Zhitong · Oct 9, 2025 at 02:53 AM
YABAO PHARM.CORP disclosed the progress of its share repurchase, having repurchased a total of 6 million shares
- Zhitong · Sep 29, 2025 at 02:41 AM
YABAO PHARM.CORP's controlling shareholder repurchased 13.65 million pledged shares in advance
